VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS20060039 | HPV | ENSG00000155511.19 | protein_coding | GRIA1 | No | No | 2890 | P42261 |
TVIS20059581 | HPV | ENSG00000155511.19 | protein_coding | GRIA1 | No | No | 2890 | P42261 |
TVIS44012693 | HTLV-1 | ENSG00000155511.19 | protein_coding | GRIA1 | No | No | 2890 | P42261 |
TVIS44025464 | HTLV-1 | ENSG00000155511.19 | protein_coding | GRIA1 | No | No | 2890 | P42261 |
TVIS44048911 | HTLV-1 | ENSG00000155511.19 | protein_coding | GRIA1 | No | No | 2890 | P42261 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | GRIA1 |
---|---|
DrugBank ID | DB09289 |
Drug Name | Tianeptine |
Target ID | BE0000640 |
UniProt ID | P42261 |
Regulation Type | modulator |
PubMed IDs | 19704408 |
Citations | McEwen BS, Chattarji S, Diamond DM, Jay TM, Reagan LP, Svenningsson P, Fuchs E: The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation. Mol Psychiatry. 2010 Mar;15(3):237-49. doi: 10.1038/mp.2009.80. Epub 2009 Aug 25. |
Groups | Investigational |
Direct Classification | Medium-chain fatty acids |
SMILES | CN1C2=CC=CC=C2C(NCCCCCCC(O)=O)C2=C(C=C(Cl)C=C2)S1(=O)=O |
Pathways | |
PharmGKB | |
ChEMBL | CHEMBL1289110 |